Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 861Lung Neoplasms 586Small Cell Lung Carcinoma 169Colorectal Neoplasms 134Breast Neoplasms 108Melanoma 101Neoplasms 91Ovarian Neoplasms 90Neoplasm Metastasis 84Pancreatic Neoplasms 75Squamous Cell Carcinoma of Head and Neck 69Stomach Neoplasms 60Carcinoma, Renal Cell 56Head and Neck Neoplasms 55Esophageal Neoplasms 49Triple Negative Breast Neoplasms 48Endometrial Neoplasms 47Prostatic Neoplasms 46Uterine Cervical Neoplasms 41Urinary Bladder Neoplasms 40Colonic Neoplasms 40Mesothelioma 38Carcinoma, Hepatocellular 36Mesothelioma, Malignant 34Brain Neoplasms 31Adenocarcinoma of Lung 29Sarcoma 28Carcinoma, Transitional Cell 28Lung Diseases 24Gastrointestinal Neoplasms 24

Interventions

pembrolizumab 1osimertinib 1durvalumab 1AZD 6244 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Non Small Cell Lung Cancer × Thoracic × 90 days × Clear all
NCT02143466 2026-04-24

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

AstraZeneca

Phase 1 Active not recruiting
344 enrolled
Thoracic

Advanced Non Small Cell Lung Cancer

NCT05777603 2026-04-09

Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
23 enrolled
Thoracic

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡